Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Interest & Investment Income (2018 - 2023)

Historic Interest & Investment Income for ProPhase Labs (PRPH) over the last 11 years, with Q4 2023 value amounting to $39000.0.

  • ProPhase Labs' Interest & Investment Income rose 3000.0% to $39000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was $39000.0, marking a year-over-year decrease of 4347.83%. This contributed to the annual value of $78000.0 for FY2023, which is 4901.96% down from last year.
  • As of Q4 2023, ProPhase Labs' Interest & Investment Income stood at $39000.0, which was up 3000.0% from $1000.0 recorded in Q3 2023.
  • Over the past 5 years, ProPhase Labs' Interest & Investment Income peaked at $230000.0 during Q3 2021, and registered a low of $1000.0 during Q3 2023.
  • Over the past 5 years, ProPhase Labs' median Interest & Investment Income value was $30500.0 (recorded in 2019), while the average stood at $53400.0.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first skyrocketed by 280000.0% in 2021, then crashed by 9600.0% in 2023.
  • Over the past 5 years, ProPhase Labs' Interest & Investment Income (Quarter) stood at $39000.0 in 2019, then plummeted by 76.92% to $9000.0 in 2020, then soared by 1133.33% to $111000.0 in 2021, then crashed by 72.97% to $30000.0 in 2022, then increased by 30.0% to $39000.0 in 2023.
  • Its Interest & Investment Income stands at $39000.0 for Q4 2023, versus $1000.0 for Q3 2023 and $27000.0 for Q2 2023.